Suppr超能文献

奇异变形杆菌与尿路感染。

Proteus mirabilis and Urinary Tract Infections.

机构信息

Department of Microbiology, New York University Langone Medical Center, New York, NY 10016.

出版信息

Microbiol Spectr. 2015 Oct;3(5). doi: 10.1128/microbiolspec.UTI-0017-2013.

Abstract

Proteus mirabilis is a Gram-negative bacterium and is well known for its ability to robustly swarm across surfaces in a striking bulls'-eye pattern. Clinically, this organism is most frequently a pathogen of the urinary tract, particularly in patients undergoing long-term catheterization. This review covers P. mirabilis with a focus on urinary tract infections (UTI), including disease models, vaccine development efforts, and clinical perspectives. Flagella-mediated motility, both swimming and swarming, is a central facet of this organism. The regulation of this complex process and its contribution to virulence is discussed, along with the type VI-secretion system-dependent intra-strain competition, which occurs during swarming. P. mirabilis uses a diverse set of virulence factors to access and colonize the host urinary tract, including urease and stone formation, fimbriae and other adhesins, iron and zinc acquisition, proteases and toxins, biofilm formation, and regulation of pathogenesis. While significant advances in this field have been made, challenges remain to combatting complicated UTI and deciphering P. mirabilis pathogenesis.

摘要

奇异变形杆菌是一种革兰氏阴性细菌,以其在表面上形成明显的牛眼状图案的强大群体运动能力而闻名。临床上,这种生物体通常是尿路感染的病原体,特别是在长期进行导管插入术的患者中。本综述重点介绍奇异变形杆菌与尿路感染(UTI)相关的内容,包括疾病模型、疫苗开发工作和临床观点。鞭毛介导的运动性,包括游泳和群体运动,是该生物体的一个核心方面。讨论了这一复杂过程的调节及其对毒力的贡献,以及在群体运动过程中依赖于 VI 型分泌系统的种内竞争。奇异变形杆菌利用多种毒力因子进入和定植宿主泌尿道,包括脲酶和结石形成、菌毛和其他黏附素、铁和锌的获取、蛋白酶和毒素、生物膜形成以及发病机制的调节。虽然在该领域取得了重大进展,但仍存在挑战,需要克服复杂的尿路感染并解析奇异变形杆菌的发病机制。

相似文献

1
Proteus mirabilis and Urinary Tract Infections.
Microbiol Spectr. 2015 Oct;3(5). doi: 10.1128/microbiolspec.UTI-0017-2013.
2
From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
Trends Microbiol. 2017 Apr;25(4):304-315. doi: 10.1016/j.tim.2016.11.015. Epub 2016 Dec 22.
3
Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
FEMS Immunol Med Microbiol. 2012 Jul;65(2):343-9. doi: 10.1111/j.1574-695X.2012.00976.x. Epub 2012 May 21.
4
Pathogenesis of Infection.
EcoSal Plus. 2018 Feb;8(1). doi: 10.1128/ecosalplus.ESP-0009-2017.
5
Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.
Nat Rev Microbiol. 2012 Nov;10(11):743-54. doi: 10.1038/nrmicro2890. Epub 2012 Oct 8.
8
Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
Med Microbiol Immunol. 2016 Apr;205(2):97-109. doi: 10.1007/s00430-015-0430-1. Epub 2015 Aug 2.
9
Pathogenesis of Proteus mirabilis in Catheter-Associated Urinary Tract Infections.
Urol Int. 2021;105(5-6):354-361. doi: 10.1159/000514097. Epub 2021 Mar 10.
10
Identification of the Indispensable Quorum Sensing Proteins of Multidrug Resistant .
Front Cell Infect Microbiol. 2018 Aug 7;8:269. doi: 10.3389/fcimb.2018.00269. eCollection 2018.

引用本文的文献

1
The high-risk factors of urinary infectious stones: a retrospective study.
Transl Androl Urol. 2025 Aug 30;14(8):2171-2184. doi: 10.21037/tau-2025-244. Epub 2025 Aug 26.
2
Proteus mirabilis in ICU Patients: Prevalence, Risk Factors, and Future Expectations of Bloodstream Infections.
Cureus. 2025 Aug 27;17(8):e91083. doi: 10.7759/cureus.91083. eCollection 2025 Aug.
4
Genomic Insights of Emerging Multidrug-Resistant OXA-48-Producing ST135 .
Antibiotics (Basel). 2025 Jul 25;14(8):750. doi: 10.3390/antibiotics14080750.
5
-species-associated periprosthetic hip and knee joint infections - a 15-year cohort analysis.
J Bone Jt Infect. 2025 Aug 11;10(4):265-275. doi: 10.5194/jbji-10-265-2025. eCollection 2025.
6
CAUTIon - not all UTIs are the same.
Nat Rev Urol. 2025 Aug 1. doi: 10.1038/s41585-025-01065-z.
7
Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease.
Pharmaceuticals (Basel). 2025 Jul 12;18(7):1038. doi: 10.3390/ph18071038.
8
An Atypical Manifestation of Cellulitis Induced by Proteus mirabilis.
Cureus. 2025 Jun 2;17(6):e85249. doi: 10.7759/cureus.85249. eCollection 2025 Jun.
9
Pathogen distribution and risk factors of positive stone culture for patients with upper urinary tract stone.
Am J Transl Res. 2025 May 15;17(5):3658-3664. doi: 10.62347/GSAT9658. eCollection 2025.
10
Clinical Case-control Study of Postoperative Ocular Microbiota Colonization Using Microbial Analysis in Patients Undergoing Blepharoplasty.
Plast Reconstr Surg Glob Open. 2025 Jun 17;13(6):e6876. doi: 10.1097/GOX.0000000000006876. eCollection 2025 Jun.

本文引用的文献

1
Characterization of 17 chaperone-usher fimbriae encoded by Proteus mirabilis reveals strong conservation.
J Med Microbiol. 2014 Jul;63(Pt 7):911-922. doi: 10.1099/jmm.0.069971-0. Epub 2014 May 8.
2
In vitro studies of epithelium-associated crystallization caused by uropathogens during urinary calculi development.
Microb Pathog. 2014 Jun-Jul;71-72:25-31. doi: 10.1016/j.micpath.2014.04.007. Epub 2014 May 4.
3
Genome Sequence of Proteus mirabilis Clinical Isolate C05028.
Genome Announc. 2014 Mar 27;2(2):e00167-14. doi: 10.1128/genomeA.00167-14.
4
Soft robotic concepts in catheter design: an on-demand fouling-release urinary catheter.
Adv Healthc Mater. 2014 Oct;3(10):1588-96. doi: 10.1002/adhm.201400035. Epub 2014 Mar 25.
5
Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis.
Infect Immun. 2014 Apr;82(4):1616-26. doi: 10.1128/IAI.01652-13. Epub 2014 Jan 27.
6
Type VI secretion system effectors: poisons with a purpose.
Nat Rev Microbiol. 2014 Feb;12(2):137-48. doi: 10.1038/nrmicro3185. Epub 2014 Jan 2.
9
Multicellular bacteria deploy the type VI secretion system to preemptively strike neighboring cells.
PLoS Pathog. 2013;9(9):e1003608. doi: 10.1371/journal.ppat.1003608. Epub 2013 Sep 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验